Send us a text

Paurvi Bhatt is the Interim CEO of the Rosalynn Carter Institute for Caregivers ( https://rosalynncarter.org/ ), an organization that drives transformative systems change to improve the strength, health, and resilience of family caregivers.

Paurvi is also the Founder and CEO of ThirdEyeFocus, a consultancy for private companies & nonprofits focused on the care economy.

Paurvi is a global healthcare executive known for creating strategies that optimize public, private, and philanthropic capital to expand more equitable decisions, resources, and care outcomes in communities around the world. She’s known for creating unique solutions that bring together nonprofits, government and companies to pilot, pivot, and scale health care and social services.

As a second generation, Indian immigrant, and family caregiver, Paurvi focuses on culturally responsive solutions in the care economy by integrating community-led voices, solutions, and organizations to shape the referral pathway that brings care into the home.

As a board director, leader and advisor on several private company, foundation, institution and nonprofit boards, Paurvi combines her lived experience with her seasoned focus on outcomes and deep knowledge of financing.

Paurvi has focused much of her career on HIV/AIDS; women’s health and health equity worldwide and is trained in health systems and economics with a B.A. in Neuroscience from Northwestern University, an M.P.H from Yale University (Health Management and Population Economics), and a PhD (ABD - Global Health Systems and Economics) from Johns Hopkins University.

Paurvi is an active spokesperson, author, podcast guest and presenter on issues ranging from women’s leadership, Asian American and immigrant issues, health systems and economics, philanthropy, HIV and women’s health, and the role of women as working daughters and family caregivers.

#PaurviBhatt #TheRosalynnCarterInstituteForCaregivers #Caregivers #CareEconomy #Caregiving #Dementia #Cancer #CorporateSocialResponsibility #Philanthropy #WomensHealth #HIV #AIDS #MedtronicFoundation #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

Support the show

Send us a text

Dr. Mark Jacobs is the Director of Pacific Technical Support and WHO Representative to the South Pacific. He was appointed in this position in August 2021. Prior to this, he has held a series of senior public health leadership roles.

Dr. Jacobs was previously the WHO Representative to Lao People’s Democratic Republic from November 2018 to August 2021. From May to October 2018, Dr Jacobs was Acting Director of Programme Management for WHO in the Western Pacific Region. He was also previously the Director of Communicable Diseases in the Region for 5 years.

Before joining WHO, Dr. Jacobs was New Zealand’s Director of Public Health for 9 years and managed the Public Health Programme at the Secretariat of the Pacific Community for 3 years. He also spent several years in Director of Public Health roles for state health authorities in Australia.

Dr. Jacobs’ interests include developing healthy public policy, strengthening disease surveillance, strengthening all hazards emergency preparedness, and working across sectors to improve health.

Dr. Jacobs holds a Bachelor of Medicine, Bachelor of Surgery, a Graduate Diploma in Health Services Management and a Master of Public Health.

#MarkJacobs #WHO #WorldHealthOrganization #SouthPacific #CommunicableDiseases #PublicHealth #DiseaseSurveillance #AllHazardsEmergencyPreparedness #InfectiousDisease #Fiji #NoncommunicableDiseases #WesternPacificRegion #HealthSecurity #AntimicrobialResistance #OneHealth #Aging #Ageing #Healthspan #Anxiety #Loneliness #Depression #ClimateChange #AirPollution #EnvironmentalHazards #PacificIslands #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

Support the show

Send us a text

Dr. Samir Khleif, MD is CEO of Georgiamune ( https://www.georgiamune.com/team ), a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases.

Dr. Khleif is a pioneer in the field of immunotherapy. He is a medical oncologist, immunologist, innovator, and entrepreneur, as well as a transformational executive in health care and biomedical research.

Prior to becoming CEO of Georgiamune, Dr. Khleif served in different academic and leadership positions. He was a National Cancer Institute (NCI)/National Institutes of Health (NIH) scientist and Chief of the NCI Cancer Vaccine Section, where he led the development of pioneering immune-oncology and cancer vaccines into clinical trials. As a national and international academic leader, and detailed by the US government, he served as the founding director and CEO of the King Hussein Cancer Center ( https://www.khcc.jo/en ) in Amman, Jordan, where he led the development of the largest cancer center in the MENA region. He also served as the director of the Georgia Cancer Center, the state cancer center, at Augusta University. He is currently a biomedical scholar and holds a professorship at Georgetown University Medical School.

Dr. Khleif also served as a Special Assistant to the Commissioner of the FDA, leading the FDA's Critical Path Initiative for Oncology. He is a member of the board of directors of Ayala Pharmaceuticals and Emerald Biopharmaceutics, and served as a member of the scientific advisory board of more than 20 biotechnology and pharmaceutical companies.

Dr. Khleif is an international KOL in immunology and immunotherapy. He has served on many national committees, including the Scientific Advisory Board of the Biden Cancer Initiative, as chair of the Immunotherapy Committee for NRG, and as a member of the NCI Cooperative Group. He currently serves as an advisor for the Parker Institute for Cancer Immunotherapy.

Dr. Khleif is an editor of three books, the author of hundreds of peer-reviewed scientific research articles, and a prolific inventor with more than 150 patents issued or pending in the field of immunology and immunotherapy.

Dr. Khleif received his medical degree at the University of Jordan, Amman Jordan. He completed his residency in Internal Medicine at the Medical College of Ohio and his fellowship in Medical Oncology at the National Cancer Institute (NCI) in Bethesda, Maryland.

#SamirKhleif #Georgiamune #Immunotherapy #KingHusseinCancerCenter #CriticalPathInitiative #FDA #Tregs #RegulatoryTCells #Cancer #Oncology #CheckpointInhibitors #ImmuneEscapeMechanisms #DualFunctioningAntibody #Autoimmune #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #Research

Support the show